Given results of the IDEA study presented at ASCO, would you consider truncating adjuvant therapy with stage II colon cancer?

Topics: Gastrointestinal Cancers • Medical Oncology

For those that do receive adjuvant therapy with stage II disease, we know magnitude of benefit to be lower. If the decision is made to administer chemotherapy, is 3 months reasonable? If 3 months is acceptable in low-risk stage III disease, should 3 months be sufficient with stage II disease?

Answer from: Medical Oncologist at Academic Institution

The question asked is how one would consider incorporating the recent findings from the IDEA study into the utilization of adjuvant chemotherapy for patients with stage II colon cancer. The findings from this landmark study indicated that under certain circumstances, specifically those of patients w...

Comments

Medical Oncologist at Kaiser Permanente
Dr Neugut, would you consider Xeloda alone x 6 mo...

Related Questions